Previous studies revealed that some bioactive food components have anti-cancer effects. However epigenetic effects of dietary compound resveratrol are largely unknown in breast cancer cells (M.A. Dawson, T. Kouzarides, 2012) [1]. Here we provide novel data and comparisons of DNA methylation status of promoter gene regions in response to resveratrol treatment at 24 h and 48 h versus untreated MDA-MB-231 breast cancer cells. DNA methylation changes were measured using Array-PRIMES method (aPRIMES) followed by whole-genome hybridization using human DNA methylation promoter microarray NimbleGen HG18 Refseq Promoter 3 Â 720 K array. Our data were associated to corresponding changes in mRNA expression in a set of cancer-related genes. Using gene ontology analysis we also identify cancer-related cellular processes and pathways that can be epigenetically reprogramed by resveratrol. Data in this article are associated to the research articles "Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol". Medina Aguilar et al., PLoS ONE 11(6): e0157866.
a b s t r a c t
Previous studies revealed that some bioactive food components have anti-cancer effects. However epigenetic effects of dietary compound resveratrol are largely unknown in breast cancer cells (M.A. Dawson, T. Kouzarides, 2012) [1] . Here we provide novel data and comparisons of DNA methylation status of promoter gene regions in response to resveratrol treatment at 24 h and 48 h versus untreated MDA-MB-231 breast cancer cells. DNA methylation changes were measured using Array-PRIMES method (aPRIMES) followed by whole-genome hybridization using human DNA methylation promoter microarray NimbleGen HG18 Refseq Promoter 3 Â 720 K array. Our data were associated to corresponding changes in mRNA expression in a set of cancer-related genes. Using gene ontology analysis we also identify cancer-related cellular processes and pathways that can be epigenetically repro- 
Specifications Table

Subject area
Biology More specific subject area
Breast cancer, Epigenetics
Type of data Tables, figure, raw data on DNA methylation (peak scores) How data was acquired Array-PRIMES method (aPRIMES). NimbleGen HG18 Refseq Promoter 3 Â 720 K arrays. Data format Filtered for peak annotation, and analyzed for differential enrichment and gene ontology Experimental factors DNA from untreated and treated MDA-MB-231 cells with resveratrol (100 mM) at 24 h and 48 h was extracted using the DNeasy Kit (Qiagen, Germany). To identify methylated and unmethylated DNA regions in the promoters of genes, we used Array-PRIMES method (aPRIMES 
Value of the data
First analysis on DNA methylation of promoter genes in triple negative breast cancer cells treated with resveratrol, spanning 27,728 CpG loci.
Provides genomic data indicating that resveratrol impacts the epigenetic landscape by changing DNA methylation status of specific oncogenes and tumor suppressor genes in breast cancer cells.
Analyses indicate that resveratrol epigenetically alters regulation of particular genes involved in cancer in triple negative breast cancer cells.
Data provided here serves as a novel and free resource for researchers working in the field of epigenetic regulation of cancer related genes in response to naturally occurring dietary compounds.
Data
In this study we performed a genome-wide survey of DNA methylation in MDA-MB-231 triplenegative breast cancer cells exposed to resveratrol [1, 3] . To determine the methylated and unmethylated DNA regions in the promoters of genes we used Array-PRIMES method (aPRIMES) [ [4] , Fig. 1 ]. The extensive annotation of peaks differentially enriched for DNA methylation and peak comparisons between the MDA-MB-231 breast cancer cells treated with resveratrol at 24 h and 48 h versus untreated cells (Tables 1, and 2) were performed using the DEVA 1.2.1 software [2] . At 24 h treatment, 338 out of 2035 hypermethylated genes correspond to cancer genes; and 92 out of 1738 hypomethylated genes correspond to cancer genes. At 48 h treatment, 137 out of 1869 hypermethylated genes were cancer genes; and 288 out of 1661 hypomethylated genes are cancer genes (Tables 3 and  4 ). In addition, differentially methylated probes and differentially expressed genes were identified between the MDA-MB-231 cells treated with resveratrol at 24 h and 48 h and the MDA-MB-231 untreated. The integrative analysis of DNA methylation and gene expression at different times of resveratrol exposure showed that changes in DNA methylation were associated to corresponding changes in mRNA expression in a set of cancer-related genes (Tables 5 and 6 ). Array-PRIMES procedure and NimbleGen HG18 Refseq Promoter 3 Â 720 K arrays analysis. Genomic DNA (500 ng) was restricted to completion with MseI restriction enzyme. Then, DNA fragments produced by MseI were subjected to linkermediated PCR. Half of the resulting ligated MseI fragments were digested with McrBC restriction enzyme while the other half of MseI fragments was digested with the two methylation-sensitive endonucleases HpaII and BstUI. The experimental and control DNA was labeled with Cy3 and Cy5 nonamers. Methylated DNA fractions are highlighted in red and are expected to result in positive ratios and green spots indicate unmethylation and are to have negative ratios. DNA methylation analysis raw data was normalized and differential intensity of each probe compared with input control was calculated using the NimbleGen software DEVA. Average fold change (experimental IP sample versus Control input sample) in a range of 2.44 kb upstream and 610 bp downstream window from RefSeq transcription start sites (TSS). Modified from Pfister, S., Schlaeger, C., Mendrzyk, F., Wittmann, A., Benner, A., Kulozik, A., et al. Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma. Nucleic Acids Res. (2007) 35:e51. C5orf39  NM_147161  chr1  199882046  199882901  2,37  NAV1  NM_018473  chr9  93900029  93900662  2,37  SPTLC1  NM_006821  chr1  24599933  24600693  2,37  C1orf201  NM_007274  chr21  46892750  46893489  2,37  PRMT2  NM_005469  chr3  185026706  185028573  2,36  MAP6D1  NM_001037171  chr2  86104655  86105502  2,36  LOC90784  NM_004035  chr6  3085344  3085995  2,35  BPHL  NM_003501  chr2  65394212  65394839  2,35  SPRED2  NM_001142807  chr1  227471486  227472810  2,34  RAB4A  NM_001111036  chr20  60293922  60294583  2,34  OSBPL2  NM_152282  chr2  27044598  27045242  2,33  MAPRE3  NM_033068  chr3  48454873  48455707  2,33  CCDC51  NM_052957  chr10  1137781  1138492  2,33  WDR37  NM_025149  chr20  56158151  56159807  2,33  C20orf85  NR_023316  chr5  354862  357457  2,32  AHRR  NM_032501  chr9  135267013  135268048  2,32  REXO4  NM_001141945  chr12  103674747  103675398  2,32  CHST11  NM_001101  chr4  38366523  38367250  2,32  KLF3  NM_005159  chr22  18131439  18132080  2,32  TBX1  NM_001615  chr12  1594042  1594714  2,31  WNT5B  NM_016188  chr5  16754086  16754821 2,30 MYO10 NM_006686 CACNB4  NM_001633  chr17  7933308  7934143  2,14  ALOX12B  NM_001144  chr1  219121014  219121672  2,14  HLX  NM_030943  chr2  27457537  27459170  2,14  PPM1G  NM_000036  chr17  15463136  15463709  2,14  CDRT1  NM_000480  chr3  73017682  73018439  2,13  GXYLT2  NM_133463  chr22  19383009  19384389  2,13  TMEM191A  NM_001033569  chr19  52711228  52711938  2,13  NAPA  NR_026903  chr13  113157300  113158153  2,13  DCUN1D2  NM_001002244  chr1  16832002  16832449  2,13  CROCCP2  NM_013366  chr10  105606512  105607450  2,13  SH3PXD2A  NM_001145  chr7  6279408  6280147  2,13  CYTH3  NM_015305  chr12  123374687  123375942  2,13  NCOR2  NM_001146  chr16  726949  727598  2,13  NARFL  NM_001118887  chr14  104784128  104785057  2,12  BRF1  NM_001142446  chr21  45185933  45186674  2,12  C21orf70  NM_020987  chr9  99001128  99001684  2,12  ZNF322B  NM_016376  chr11  62403221  62404093  2,12  SLC3A2  NM_054027  chr13  112851148  112851681  2,12  F10  NM_015114  chr20  4648316  4649183  2,12  PRND  NM_016552  chr16  463734  465061  2,12  RAB11FIP3  NM_017664  chr20  48178979  48180250  2,12  TMEM189  NM_013275  chr1  43658960  43660815  2,12  KIAA0467  NM_152345  chr1  90231647  90232482  2,12  GEMIN8P4  NR_026868  chr1  9338507  9339158  2,11  SPSB1  NM_001012421  chr1  201962916  201963647  2,11  ATP2B4  NM_001012419  chr15  61674213  61674782  2,11  FBXL22  NM_001098805  chr9  135214287  135215030  2,11  SURF2  NM_144994  chr11  116606198  116606846  2,11  PCSK7  NM_133475  chr7  23421191  23421918  2,11  IGF2BP3  NR_026556  chr5  180189349  180190218  2,11  LOC729678  NR_027020  chr5  140772911  140773568  2,11  PCDHGA10  NM_153697  chr19  46593106  46593861  2,10  EXOSC5  NM_001115116  chr15  32183123  32183750  2,10  PGBD4  NM_138797  chr7  134112594  134113325  2,10  CALD1  NM_024669  chr15  84102740  84103387  2,10  KLHL25  NM_023016  chr19  2379640  2381804  2,10  LMNB2  NM_001105576  chr4 8504610 8507474 2,10 C4orf23 NM_020140 FOXC1  NM_021071  chr8  146021440  146021889  2,03  ZNF7  NM_139058  chr7  72064829  72065286  2,03  NSUN5P2  NM_018482  chr9  129582203  129583046  2,02  SH2D3C  NM_001135191  chr10  74926545  74927317  2,02  USP54  NM_001040445  chr1  226361765  226362490  2,02  MRPL55  NM_024701  chr7  98470784  98471533  2,02  SMURF1  NM_212556  chr7  100675731  100676278  2,02  FIS1  NM_016150  chr3  129709277  129710016  2,02  LOC90246  NM_016116  chr18  69967812  69968570  2,02  C18orf55  NM_177999  chr19  2750403  2751132  2,02  THOP1  NM_014034  chr4  7804401  7805550  2,02  AFAP1AS  NM_004674  chr20  51926997  51927566  2,02  SUMO1P1  NM_001672  chr3  197777980  197778910  2,02  WDR53  NM_004043  chr11  66245244  66246291  2,02  SPTBN2  NM_004192  chr19  2082237  2082992  2,02  AP3D1  NM_152792  chr11  71492967  71494231  2,02  LRTOMT  NM_024083  chr5  114628333  114628885  2,01  PGGT1B  NM_014065  chr6  90081076  90081725  2,01  GABRR2  NM_198186  chr7  149731981  149732428  2,01  LOC728743  NM_018188  chr22  37738715  37739318  2,01  APOBEC3C  NM_031921  chr20  37022165  37022900  2,01  DHX35  NM_001039211  chr11  57262894  57263532  2,01  TMX2  NM_033064  chr13  113143850  113144500  2,01  ADPRHL1  NM_001030287  chr17  4554829  4555791  2,01  PELP1  NM_030803  chr8  103946748  103947289  2,01  AZIN1  NM_033388  chr2  70635358  70636107  2,01  TGFA  NM_024085  chr19  16145082  16145738  2,01  CIB3  NM_024490  chr9  115702649  115703348  2,01  ZNF618  NM_032189  chr6  33278127  33278983  2,01  SLC39A7  NM_024524  chr6  44228307  44228832  2,01  TMEM63B  NM_000702  chr10  35574617  35575279  2,01  CCNY  NM_001135765  chr11  130292597  130293452  2,01  SNX19  NM_174953  chr17  36507252  36508001  2,01  KRTAP4-8  NM_001001396  chr5  111123614  111124276  2,01  C5orf13  NM_001002031  chr11  124050683  124051236 2,00 SPA17 NM_001003713 chr4  6975976  6976625  2,00  TBC1D14  NM_001017971  chr14  19994926  19995487  2,00  APEX1  NM_005765  chr2  68813855  68814386  2,00  ARHGAP25  NM_012463  chr10  106084059  106084715  2,00  ITPRIP  NM_152565  chr1  59532773  59533669  2,00  FGGY  NM_145230  chr10  126701787  126702422  2,00  CTBP2  NM_001695  chr7  149655954  149657392  2,00  LRRC61  NM_144583  chr1  9593002  9593729  2,00  TMEM201  NM_080653  chr17  75364548  75365507  2,00  CBX2  NM_138282  chr1  40191655  40192402  2,00  MFSD2A  NM_015941  chr4  39721670  39722341  2,00  LOC344967  NM_001105529  chr1 25106856 25107403 2,00 RUNX3 NM_138813 Table 2 Annotation of peak values indicating differentially enriched DNA methylation between the MDA-MB-231 breast cancer cells treated with resveratrol at 48 h versus non-treated cells.
Chromosome
Data start Data end Peak value ( Z 2) Gene name Accession number chr20 51631293 51631942 2,33  ZNF217  NM_006526  chr7  129718140  129719263  2,33  CPA4  NM_016352  chr14  104311019  104311666  2,32  AKT1  NM_005163  chr1  148511761  148512420  2,31  C1orf54  NM_024579  chr14  23710633  23711373  2,31  REC8  NM_005132  chr2  151827549  151828190  2,30  RBM43  NM_198557  chr7  158509814  158510485  2,27  LOC154822  NR_024394  chr17  23822375  23823405  2,26  SLC13A2  NM_001145976  chr14  95011537  95012580  2,24  C14orf49  NM_152592  chr14  22458926  22460289  2,24  PRMT5  NM_006109  chr10  99197678  99198211  2,24  ZDHHC16  NM_198046  chr2  238430809  238431646  2,20  RAMP1  NM_005855  chr1  43198303  43199496  2,20  SLC2A1  NM_006516  chr6  143931574  143932238  2,19  LOC285740  NR_027113  chr8  131022998  131023436  2,17  FAM49B  NM_016623  chr8  22024534  22025287  2,17  NUDT18  NM_024815  chr11  63747908  63749057  2,16  TRPT1  NM_031472  chr4  3496220  3496869  2,16  LRPAP1  NM_002337  chr7  34840781  34841438  2,15  NPSR1  NM_207173  chr5  94752293  94753044  2,15  FAM81B  NM_152548  chr1  199882134  199882991  2,14  NAV1  NM_020443  chr1  207865542  207866280  2,14  LAMB3  NM_001017402  chr16  16231473  16232198  2,14  NOMO3  NM_001004067  chr1  66230912  66231596  2,13  PDE4B  NM_001037341  chr8  86478784  86479521  2,13  CA1  NM_001128829  chr2  11210550  11211221  2,13  PQLC3  NM_152391  chr1  11843395  11843983  2,12  NPPB  NM_002521  chr20  36486806  36487535  2,12  SNORA71B  NR_002910  chr3  39125418  39126567  2,12  TTC21A  NM_145755  chrX  99080841  99081873  2,12  LOC442459  NR_024608  chr20  51926997  51927566  2,11  SUMO1P1  NR_002189  chr6  167718803  167720348  2,11  TCP10  NM_004610  chr7  75207943  75208630  2,10  HIP1  NM_005338  chr3  113495155  113495728  2,10  SLC9A10  NM_183061  chr17  8811092  8811749  2,10  PIK3R5  NM_001142633  chrX  69199270  69200037  2,10  OTUD6A  NM_207320  chr14  90790629  90792432  2,09  GPR68  NM_003485  chr19  14042256  14043117  2,09  LOC113230  NR_024282  chr1  177825607  177826556  2,09  TDRD5  NM_173533  chr11  73337521  73338348  2,08  DNAJB13  NM_153614  chr13 77212180 77213337 2,08 SLAIN1 NM_001040153 Table 3 List of hypermethylated and hypomethylated cancer genes in MDA-MB-231 cells expose to resveratrol at 24 h.
Out of 2035 Hypermethylated genes, 338 were cancer-related genes: Table 3 (continued )   SLC12A6, SLC9A3R1, SMARCA4, SMARCE1, SMC3, SORCS2, SOX2, SRCAP,  SRSF3, SS18L1, ST6GAL2, STAT3, STC1, STK19, STYK1, SYNE2, TAF1, TAL1, TAL2,  TBX18, TCHH, TERT, TFDP1, TFPT, TLL2, TLX3, TMEM132D, TMSL3  (TMSB4XP8), TNFAIP3, TNFRSF17, TNFSF8, TOP1, TP53, TPM4, TRAF7, TRAK1 , TRRAP, TTC18 (CFAP70), TUBA3C, U2AF1, UBR5, VWF, WAC, WAS, WDFY3, WHSC1, WIPF2, WNT2, WT1, XBP1, XPA, XPC, ZFR2, ZFX, ZNF331, ZNF469, ZNF497, ZNF750. Out of 1738 Hypomethylated genes, 92
were cancer-related genes:
ABCA7, ABLIM2, AHNAK, ALS2CL, ARHGAP28, ATP2B3, ATP2C2, ATRX, C19ORF26, C1QL2, C2CD4C, CCDC63, CCND1, CCT8L2, CD79B, CDK13, CHD7, CHST1, CLK3, CNGA4, COL9A2, COX6C, CRTC3, CSMD3, CTNNA2, CYP2E1, DCAF12L2, DDB2, EGFLAM, ERCC2, ERCC6, ETV5, EVPL, FAM58A, FLI1, FLT1, FOXO3, FTCD, GNAT1, HCN1, HOXA9, IGF2, IGF2R, IKZF1, IRF4, KEAP1, KHSRP, LIFR, LMX1A, LPHN1, MED12, MSR1, MST1, MST1R, MUC6, MYCL1 (MYCL), MYD88, MYH9, MYOM2, NEUROG2, NRG2, OR51I2, P2RY8, PCDHB6, PHOX2B, PLCH2, POLE, PPP1R3A, PPP6R2, PROM1, RASGEF1A, RFTN1, RPL5, RYR1, SALL3, SEMA5B, SETBP1, SIGLEC1, SOX9, SPTBN4, STK11, TCF3, TLR2, TMPRSS2, TNFRSF14, TRAF5, TSC2, WDR24, WIF1, ZMYND10, ZNF536, ZZEF1. 2. Experimental design, materials and methods
Genome-wide analysis of DNA methylation
High molecular weight DNA from MDA-MB-231 triple negative breast cancer cell line untreated and treated with resveratrol (100 mM) at 24 h and 48 h was extracted using the DNeasyKit (Qiagen, Germany) according to the manufacturer's instructions. For detection of the methylation status of CpG islands (CGIs), we used array-based profiling of reference-independent methylation status (aPRIMES) technology in MDA-MB-231 cells untreated and treated with resveratrol at 24 h and 48 h. This method is based on the differential restriction and competitive hybridization of methylated and unmethylated DNA by methylation-specific and methylation-sensitive restriction enzymes, and NimbleGen HG18 Refseq Promoter 3 Â 720 K array to measure the differential DNA methylation as described in Fig. 1 . Briefly, genomic DNA (500 ng) was restricted with MseI enzyme (New England Biolabs) and ligated to adapter primers according to the recommendations of the supplier. Then, onehalf of the ligated MseI fragments were digested with the methylation-sensitive restriction enzymes HpaII and BstUI to cut unmethylated CGIs, and the remaining half is digested with the methylationspecific enzyme McrBC to cut CGIs methylated. Restricted samples were then subjected to 20 cycles of linker-mediated PCR, differentially labeled with fluorescent dyes Cy3 and Cy5, and competitively hybridized to a NimbleGen HG18 Refseq Promoter 3 Â 720 K array following the conditions recommended by the supplier. DNA methylation analysis raw data was normalized and differential intensity Table 4 (continued )   PXDN, RADIL, RASGEF1A, RBMX, RFTN1, RGS12, RHOB, RHOH, RNF213, RNF43,  RPL5, RPTOR, RUNDC2A (SNX29), RXRA, RYR1, SALL3, SCN11A, SCN5A,  SDHAF2, SEMA5B, SEPT7P2, SETBP1, SH3GL1, SIGLEC1, SMC3, SORCS2, SOX9,  SPTBN4, SRCAP, SS18L1, ST6GAL2, STC1, STK11, STK19, SYNE2, TAL2, TBX18,  TCF3, TCHH, TERT, TFDP1, TFPT, TLL2, TLR2, TMEM132D, TMPRSS2, TMSL3  (TMSB4XP8), TNFRSF14, TOP1, TP53, TRAF5, TRAF7, TRRAP, TSC2, TTC18  (CFAP70) , TUBA3C, WAS, WDR24, WHSC1, WIF1, WIPF2, WT1, XPA, XPC, ZFR2, ZMYND10, ZNF331, ZNF469, ZNF497, ZNF536, ZZEF1. of each probe compared with experimental IP sample (IP) and control input sample (input) was calculated using the NimbleGen software DEVA. Average fold change (IP versus input) each 50 bp bin for a range of 2.44 kb upstream and 610 bp downstream window from RefSeq transcription start sites (TSS). The methylation peak values were mapped to features using DEVA software. Regions showing enrichment at 4 or more consecutive loci were integrated together to form a single "peak". Clusters of enriched regions separated by more than 500 base pairs were integrated as separate peaks, which reflected the probability of methylation for the designated peak and/or gene at a p-value of less than 0.01. The functional annotation of target genes based on Gene Ontology was performed using DAVID (Database for Annotation, Visualization and Integrated Discovery).
Raw data processing and statistical analysis
A two way ANOVA was performed to identify differentially methylated genes. Only genes with statistically significant differences in DNA methylation levels (p-value o0.05) were included. 
